共 190 条
[1]
Pacella E(2012)Testing the effectiveness of intravitreal ranibizumab during 12 months of follow-up in venous occlusion treatment Clin Ter 163 e413-e422
[2]
Pacella F(2014)Incidence of presumed endophthalmitis after intravitreal injection performed in the operating room: a retrospective multicenter study (Retina Philadelphia, Pa) 34 12-17
[3]
La Torre G(2017)Low endophthalmitis rates after intravitreal anti-vascular endothelial growth factor injections in an operation room: a retrospective multicenter study Retina (Philadelphia, Pa) 37 2341-2346
[4]
Impallara D(2016)Management of anterior chamber dislocation of a dexamethasone intravitreal implant: a case report J Med Case Reports 10 282-606
[5]
Malarska K(2021)Incidence of endophthalmitis after intravitreal injection with and without topical antibiotic prophylaxis Eur J Ophthalmol 31 600-3617
[6]
Brillante C(2020)Effects of repeated intravitreal injections of dexamethasone implants on intraocular pressure: a 4-year study Clinical ophthalmology (Auckland, NZ) 14 3611-441
[7]
Turchetti P(2018)Topical antibiotics and intravitreal injections Acta Ophthalmol 96 435-401
[8]
De Giusti M(2019)No increase in incidence of post-intravitreal injection endophthalmitis without topical antibiotics: a prospective study Jpn J Ophthalmol 63 396-292
[9]
Casparis H(2020)Endophthalmitis following intravitreal injection of anti-vascular endothelial growth factor agents Canadian journal of ophthalmology Journal canadien d'ophtalmologie 55 286-1637
[10]
Wolfensberger TJ(2006)Penetration of topically applied levofloxacin 0.5% and ofloxacin 0.3% into the vitreous of the non-inflamed human eye Graefes Arch Clin Exp Ophthalmol= Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 244 1633-491